XEDEV is a CRO/CDMO specialized in formulation and process development for solid dosage forms, with capabilities to develop early-phase formulations up to clinical phase for different administration routes. XEDEV offers formulation and process development of drug products via drying, granulation, tableting and coating processes, different analytical tools to characterize drug substances and products (solid state, powder/tablet characterization, assay and purity analysis), and clinical batch production up to Phase IIb.

No comments available.
Leave your rating & comment